Vaccine trial patient claims was permanently disabled after taking AstraZeneca’s COVID vaccine; here’s wh – The Times of India

2 minutes, 9 seconds Read

Amidst growing concerns around the safety of COVID vaccines developed by AstraZeneca, a new claim has come to the fore. A 42 year old American woman has claimed that she was “permanently disabled” after taking AstraZeneca’s COVID vaccine during the clinical trial process. She also claims that her disability was due to the failure by the drug maker in providing her with medical care when she developed side effects.
“Brianne Dressen, a 42-year-old former teacher from Utah, says she developed a severe neurological condition after taking part in a vaccine trial in 2020. She is suing AstraZeneca for an alleged breach of contract, after she said it failed to provide medical care for her side effects,” The Telegraph reported. It is believed to be the first of its kind lawsuit in the US.

What happened to her?

“…she experienced a severe sensation of pins and needles across her body shortly after she received the jab in November 2020,” as per the media report. She was later diagnosed with peripheral neuropathy, her condition was classified as “post vaccine neuropathy”.
Post-vaccine neuropathy is a rare condition where nerve damage occurs after vaccination, leading to symptoms like pain, tingling, numbness, or muscle weakness. It is believed to result from an immune response triggered by the vaccine. Most cases are mild and temporary, resolving within weeks to months. Treatment focuses on symptom management, including pain relief and physical therapy. The occurrence of such adverse side effects is concerning.

“This thing took me out of my job – I’m still permanently disabled,” she said. “I still have that horrific nightmare of the pins and needles sensation coursing through my body, head to toe, 24 hours a day, seven days a week,” she told Telegraph.

Ads


Sponsor A War Children Today: 
SaveWorldChildren.org

TTS, the rare side effect AstraZeneca admitted in court documents

AstraZeneca has admitted of the occurrence of TTS or Thrombosis Thrombocytopenia Syndrome. Thrombosis Thrombocytopenia Syndrome (TTS) is a rare but serious condition characterized by the formation of blood clots (thrombosis) combined with low platelet counts (thrombocytopenia). Symptoms typically appear within two weeks post-vaccination and include severe headaches, abdominal pain, leg swelling, and shortness of breath.

Not just Brianne, more than 50 people in the UK have already filed lawsuits against the British pharma company. Several parents in India are suing Serum Institute of India, the manufacturer of AstraZeneca vaccine Covishield in India. Meanwhile, AstraZeneca has withdrawn its COVID vaccine worldwide citing commercial reasons; the move came only a few weeks after its admission in court documents regarding the possibility of rare side effects due to the vaccine.

Eligibility criteria for having a heart transplant and how to prepare?

This post was originally published on 3rd party site mentioned in the title this site

Similar Posts